ChristineHeesunKimMDFACOG, FACS

PubMed

• Immunotherapy May Improve Tumor Sensitivity to Palliative Chemotherapy in Platinum Resistant Ovarian Cancer.
  Rachel E Kinney, Suresh Nair, Christine H Kim, M Bijoy Thomas, Martin DelaTorre
  The Oncologist. 2023-06-02
• 5 citations
  The compliance with a patient-safety bundle for management of placenta accreta spectrum†.
  Johanna Quist-Nelson, Aislinn Crank, Emily A. Oliver, Christine H. Kim, Scott D. Richard
  The Journal of Maternal-Fetal & Neonatal Medicine. 2021-09-01
• 4 citations
  Managing opioid use in the acute surgical setting: A society of gynecologic oncology clinical practice statement.
  Christine H. Kim, Carolyn Lefkowits, Christine H. Holschneider, Kristin Bixel, Bhavana Pothuri
  Gynecologic Oncology. 2020-06-01

Journal Articles

• Update on Uterine Sarcomas  
  Conigliaro KM, Kim CH, Postgraduates Obstetrics and Gynecology, 1/1/2015
• Immunotherapy for gynecologic malignancies: the way forward  
  Kim CH, Schilder RJ, Am J Hematology/ Oncology, 1/1/2014
• Adjuvant vaginal cuff brachytherapy for high-risk, early stage endometrial cancer  
  Eldredge-Hindy H, Eastwick G, Anne PR, Rosenblum NG, Schilder RJ, Chalian R, Zibelli AM, Kim CH, Den R, J Contemp Brachytherapy, 1/1/2014
• Cryptic reproductive isolations in the Drosophila simulans species group  
  Price CSC, Kim CH, Gronlund CJ and Coyne JA, Evolution, 1/1/2001
• Mechanisms of conspecific sperm precedence in Drosophila  
  Price CSC, Kim CH, Poluszny J and Coyne JA, Evolution, 1/1/2000
• Join now to see all

Abstracts/Posters

• Nomogram Predicting 5-Year Progression Free Survival After Secondary Surgical Cytoreduction for Platinum-Sensitive Recurrent Ovarian Cancer
  Kim CH, Kou L, Yu C, Taylor J, Zivanovic O, Barakat RR, Makker V, Kattan MW, Chi DS, Society of Gynecologic Oncology’s 2014 Annual Meeting, Los Angeles, CA, 1/1/2014
• Predicting Overall Survival After Secondary Surgical Cytoreduction for Platinum-Sensitive Recurrent Ovarian Cancer: A Prognostic Nomogram
  Kim CH, Kou L, Yu C, Conroy EM, Brown CL, Abu-Rustum NA, Gardner GJ, Makker V, Kattan MW, Chi DS, Society of Gynecologic Oncology’s 2014 Annual Meeting, Los Angeles, CA, 1/1/2014
• Nanometastases in endometrial cancer to sentinel lymph nodes: the contribution of pathologic ultrastaging
  Kim CH, Khoury-Collado F, Barlin JN, Park KJ, Cassella DK, Sonoda Y, Hensley ML, Chi DS, Barakat RR, Abu-Rustum NR, Society of Gynecologic Oncology’s 2012 Annual Meeting/New York Obstetrical Society Residents and Fellows Research Day, Austin, TX, 2012; New York, NY, 2012, 1/1/2012
• The importance of applying a sentinel lymph node mapping algorithm in endometrial cancer staging: Beyond removal of blue nodes
  Barlin JN, Khoury-Collado, Kim CH, Leitao MM Jr, Chi DS, Sonoda Y, Alektiar K, Delair DF, Barakat RR, Abu-Rustum NR, Society of Gynecologic Oncology’s 2012 Annual Meeting, Austin, TX, 1/1/2012
• Incidence of sentinel lymph node metastasis in endometrial carcinoma: correlation with tumor grade and myometrial invasion
  Khoury-Collado F, Alchyib O, Kim CH, Barlin JN, Cassella D, Sonoda Y, Leitao MM Jr, Chi DS, Barakat RR, Abu-Rustum NR, Society of Gynecologic Oncology’s 2012 Annual Meeting, Austin, TX, 1/1/2012
• Reproductive outcomes of patients undergoing radical trachelectomy for early-stage cervical cancer
  Kim CH, Abu-Rustum NR, Chi DS, Gardner GJ, Leitao Jr MM, Carter J, Barakat RR, Sonoda Y, Society or Gynecologic Oncology’s 2011 Annual Meeting, Orlando, FL, 1/1/2011
• Oncologic outcomes of radical trachelectomy at a single institution
  Kim CH, Abu-Rustum NR, Chi DS, Gardner GJ, Leitao Jr MM, Barakat RR, Sonoda Y, Society of Gynecologic Oncology’s 2011 Annual Meeting, Orlando, FL, 1/1/2011
• Tumor expression of the type I insulin-like growth factor receptor is an independent prognostic factor in epithelial ovarian cancer
  Huang G, Herbert T, Kim CH, Lin J, Arias-Pulido H, Smith H, Society of Gynecologic Oncology’s 2011 Annual Meeting, Orlando, FL, 1/1/2011
• Evaluation of insulin-like growth factor 2 (IGF2) expression in primary epithelial ovarian tumors
  Kim C, Albert Einstein College of Medicine/ Montefiore Medical Center, New York, NY, 1/1/2009
• The predictive value of a drug resistance assay in highrisk uterine cancers: A pilot study
  Owers RL, Bamira DG, Sakaris A, Kim CH, Kuo DY, Huang GS, Shahabi S, Novetsky AP, Goldberg GL, Einstein ML, Society of Gynecologic Oncology’s 2008 Annual Meeting, 1/1/2008
• An Anatomical Study of Conspecific Sperm Precedence in Drosophila simulans and Drosophila mauritiana
  Kim CH, Price CSC, Coyne JA, The University of Chicago, Chicago, IL, 1/1/1998
• Join now to see all

Lectures

• The Use of Sentinel Lymph Node Mapping in Endometrial Cancer 
  King of Prussia, PA - 1/1/2015
• Advances in Minimally Invasive Treatment of Gynecologic Cancers 
  Thomas Jefferson University Hospital, Philadelphia, PA - 1/1/2014
• Surgical Advances in the Treatment of Early Cervical Cancer 
  Nazareth Hospital, Philadelphia, PA - 1/1/2014
• Ovarian Cancer: Recognizing the Signs and Symptoms and Getting the Facts 
  Thomas Jefferson University Hospital,Kimmel Cancer Center, Philadelphia, PA - 1/1/2013
• The cytoplasmic domain of MUC16 may be a potential ovarian tumor antigen for adoptive T-cell therapy 
  Austin, TX - 1/1/2012
• An international series on abdominal trachelectomy: 101 patients and 28 pregnancies 
  Austin, TX - 1/1/2012
• Join now to see all

Other

• The Kim Chi Procedure 
  Kim CH, Chi DS, Video presentation at The Society of Gynecologic Oncology Annual Meeting
  Austin, TX - 1/1/2012
• Reproductive outcomes in radical trachelectomy at MSKCC 
  Kim CH, Sonoda Y, Updates in Gynecologic Oncology MSKCC Newsletter
  1/1/2011